Recent TCBP News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/08/2024 08:30:07 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/06/2024 08:05:10 PM
- TCBP Announces Plan to Implement ADS Ratio Change • PR Newswire (US) • 07/31/2024 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/29/2024 08:05:26 PM
- TCBP Announces Dosing of 6th Patient in ACHIEVE Study in Patients with Acute Myeloid Leukemia • PR Newswire (US) • 07/22/2024 12:00:00 PM
- TCBP Announces Launch of Compassionate Use Program for TCB008 • PR Newswire (US) • 05/15/2024 12:30:00 PM
- TC BioPharm Announces Exercise of Warrants for £3.1 Million Gross Proceeds • PR Newswire (US) • 05/06/2024 05:01:00 PM
- TC BioPharm Announces Execution of Second Non-Binding Letter of Intent for Acquisition, Targeting Innovative CAR-T Therapies • PR Newswire (US) • 05/06/2024 12:30:00 PM
- TCBP Announces Execution of Non-Binding Letter of Intent for Acquisition of NK Platform Technologies • PR Newswire (US) • 04/04/2024 12:32:00 PM
- TCBP Increasing Treatment Capacity with Expanded Manufacturing Process • PR Newswire (US) • 04/02/2024 12:30:00 PM
- TCBP Adjourns General Meeting Until a Later Date • PR Newswire (US) • 03/19/2024 12:30:00 PM
- TCBP Announces Exercise of Series D Warrants For Cash • PR Newswire (US) • 03/18/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 11:30:38 AM
- Bryan Kobel, CEO of TCBP, Appears on Nationally Syndicated "The Big Biz Show" • PR Newswire (US) • 03/01/2024 01:30:00 PM
- /C O R R E C T I O N -- TC BioPharm/ • PR Newswire (US) • 02/27/2024 10:15:00 PM
- TCBP Announces Shareholder Update Call on March 5th 2024 • PR Newswire (US) • 02/27/2024 01:30:00 PM
- TCBP Announces MHRA Acceptance of Amendment for ACHIEVE UK Trial • PR Newswire (US) • 02/22/2024 02:32:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 02/20/2024 11:05:14 AM
- TC BioPharm Management to Participate at Upcoming 7th CAR-TCR Summit Europe • PR Newswire (US) • 02/15/2024 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 07:48:40 PM
- TCBP Provides Shareholder Update and Highlights Upcoming Milestones • PR Newswire (US) • 02/14/2024 01:30:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 02/09/2024 08:26:49 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/29/2024 02:16:48 PM
- TC BioPharm Chief Executive Officer, Bryan Kobel Featured on 'The Big Biz Show' • PR Newswire (US) • 01/29/2024 01:30:00 PM
- TC BioPharm to Present at the Sequire Investor Summit • PR Newswire (US) • 01/18/2024 01:30:00 PM
Maybacks Global Entertainment and ZEASN Technology Private Ltd. Sign Global Licensing Agreement • AHRO • Aug 8, 2024 7:00 AM
SANUWAVE Will Host a Conference Call on August 13, 2024 at 8:30 AM (ET) to Present Q2 Financial Results • SNWV • Aug 8, 2024 6:59 AM
Kona Gold Beverage Inc. Signs Letter of Intent with Bemax, Inc. to Sell Kona Gold, LLC • BMXC • Aug 7, 2024 10:00 AM
Btab Ecommerce Group, Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • BBTT • Aug 7, 2024 9:00 AM
Hydromer, Inc. Announces Preliminary Unaudited Second Quarter 2024 Financial Results and Provides Business Update • HYDI • Aug 7, 2024 8:52 AM
North Bay Resources Announces Mt. Vernon Gold Mine Startup, Sierra County, California • NBRI • Aug 5, 2024 9:00 AM